+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regenerative Medicine Market by Product, by Material, and by Application: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • ID: 4853713
  • Report
  • May 2019
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

The report covers a forecast and an analysis of the regenerative medicine market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the bioinformatics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bioinformatics market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the regenerative medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the regenerative medicine market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the regenerative medicine market on a global and regional basis.

The study provides a decisive view of the regenerative medicine market by segmenting it based on product, material, application, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players in the global regenerative medicine market include Zimmer Biomet, Stryker Corporation, Athersys, Medtronic, U.S. Stem Cell, Integra Lifesciences, Organogenesis, Acelity Holdings, CryoLife, and Isto Biologics.

This report segments the global regenerative medicine market into:

Global Regenerative Medicine Market: By Product

  • Gene Therapy
  • Cell Therapy
  • Small Molecule and Biologic
  • Tissue Engineering

Global Regenerative Medicine Market: By Material

  • Biologically Derived Material
  • Xenogeneic Material
  • Collagen
  • Synthetic Material
  • Scaffold
  • Biodegradable Synthetic Polymer
  • Hydrogel Material
  • Artificial Vascular Graft Material
  • Pharmaceuticals
  • Biologic
  • Small Molecule
  • DNA Sequencing
  • Genetically Engineered Material
  • Genetically Manipulated Cell
  • Deoxyribonucleic Acid Transfection Vector
  • Three-Dimensional Polymer Technology
  • Fibroblast
  • Transgenic
  • Gene-Activated Matrices
  • Neural Stem Cell

Global Regenerative Medicine Market: By Application

  • Oncology
  • Cardiovascular
  • Musculoskeletal
  • Dermatology
  • Ophthalmology
  • Neurology
  • Wound Healing
  • Others

Global Regenerative Medicine Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Regenerative Medicine market, 2016-2025 (USD Billion)
    • 2.2. Global Regenerative Medicine market: Snapshot
  • Chapter 3. Regenerative Medicine Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Growing incidences of genetic disorders and chronic diseases
      • 3.2.2. Increased investments by governments in regenerative medicine studies
    • 3.3. Market Restraints
      • 3.3.1. Rigorous government regulations
      • 3.3.2. High treatment costs
    • 3.4. Opportunities
      • 3.4.1. Increasing R&D activities on stem cells
      • 3.4.2. Growing focus on technological innovations all globally
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product
      • 3.6.2. Market attractiveness analysis, by Material
      • 3.6.3. Market attractiveness analysis, by Application
      • 3.6.4. Market attractiveness analysis, by Region
  • Chapter 4. Global Regenerative Medicine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Regenerative Medicine market: company market share, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  • Chapter 5. Global Regenerative Medicine Market - Product Segment Analysis
    • 5.1. Global Regenerative Medicine market: Product overview
      • 5.1.1. Global Regenerative Medicine market revenue share, by Product, 2018 and 2025
    • 5.2. Gene Therapy
      • 5.2.1. Global Regenerative Medicine market for Gene Therapy, 2016-2025 (USD Billion)
    • 5.3. Cell Therapy
      • 5.3.1. Global Regenerative Medicine market for Cell Therapy, 2016-2025 (USD Billion)
    • 5.4. Small Molecule & Biologic
      • 5.4.1. Global Regenerative Medicine market for Small Molecule & Biologic, 2016-2025 (USD Billion)
    • 5.5. Tissue Engineering
      • 5.5.1. Global Regenerative Medicine market for Tissue Engineering, 2016-2025 (USD Billion)
  • Chapter 6. Global Regenerative Medicine Market - Material Analysis
    • 6.1. Global Regenerative Medicine market: Material overview
      • 6.1.1. Global Regenerative Medicine market revenue share, by Material, 2018 and 2025
    • 6.2. Biologically Derived Material
      • 6.2.1. Global Regenerative Medicine market for Biologically Derived Material, 2016-2025 (USD Billion)
    • 6.3. Synthetic Material
      • 6.3.1. Global Regenerative Medicine market for Synthetic Material, 2016-2025 (USD Billion)
    • 6.4. Pharmaceuticals
      • 6.4.1. Global Regenerative Medicine market for Pharmaceuticals, 2016-2025 (USD Billion)
    • 6.5. Genetically Engineered Material
      • 6.5.1. Global Regenerative Medicine market for Genetically Engineered Material, 2016-2025 (USD Billion)
  • Chapter 7. Global Regenerative Medicine Market - Application Analysis
    • 7.1. Global Regenerative Medicine market: Application overview
      • 7.1.1. Global Regenerative Medicine market revenue share, by Application, 2018 and 2025
    • 7.2. Oncology
      • 7.2.1. Global Regenerative Medicine market for Oncology, 2016-2025 (USD Billion)
    • 7.3. Cardiovascular
      • 7.3.1. Global Regenerative Medicine market for Cardiovascular, 2016-2025 (USD Billion)
    • 7.4. Musculoskeletal
      • 7.4.1. Global Regenerative Medicine market for Musculoskeletal, 2016-2025 (USD Billion)
    • 7.5. Dermatology
      • 7.5.1. Global Regenerative Medicine market for Dermatology, 2016-2025 (USD Billion)
    • 7.6. Ophthalmology
      • 7.6.1. Global Regenerative Medicine market for Ophthalmology, 2016-2025 (USD Billion)
    • 7.7. Neurology
      • 7.7.1. Global Regenerative Medicine market for Neurology, 2016-2025 (USD Billion)
    • 7.8. Wound Healing
      • 7.8.1. Global Regenerative Medicine market for Wound Healing, 2016-2025 (USD Billion)
    • 7.9. Others
      • 7.9.1. Global Regenerative Medicine market for Others, 2016-2025 (USD Billion)
  • Chapter 8. Global Regenerative Medicine Market - Regional Analysis
    • 8.1. Global Regenerative Medicine market: Regional overview
      • 8.1.1. Global Regenerative Medicine market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
      • 8.2.2. North America Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
      • 8.2.3. North America Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.2.4.2. The U.S. Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.2.4.3. The U.S. Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.2.5.2. Rest of North America Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.2.5.3. Rest of North America Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
      • 8.3.2. Europe Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
      • 8.3.3. Europe Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.3.4.2. Germany Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.3.4.3. Germany Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.3.5.2. UK Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.3.5.3. UK Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.3.6.2. France Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.3.6.3. France Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.4.4.2. China Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.4.4.3. China Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.4.5.2. Japan Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.4.5.3. Japan Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.4.6.2. India Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.4.6.3. India Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
      • 8.5.2. Latin America Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
      • 8.5.3. Latin America Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.5.4.2. Brazil Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.5.4.3. Brazil Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Regenerative Medicine market revenue, by Product, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Regenerative Medicine market revenue, by Material, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Regenerative Medicine market revenue, by Application, 2016-2025 (USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Zimmer Biomet
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Drug Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Stryker Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Drug Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Athersys
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Drug Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Medtronic
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Drug Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. U.S. Stem Cell
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Drug Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Integra Lifesciences
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Drug Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Organogenesis
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Drug Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Acelity Holdings
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Drug Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. CryoLife
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Drug Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Isto Biologics
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Drug Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
Note: Product cover images may vary from those shown
Adroll
adroll